National Research (NRC) Osake Kurssi
National Research Kurssi
Viimeisten 19 vuoden aikana National Researchn liikevaihto kasvoi 6,2 % vuodessa ja ylsi 137,39 M USD:een. Osakekohtainen tulos on laskenut 2,5 % vuodessa viimeisten 19 vuoden aikana. National Researchn nettomarginaali 8,4 % on laskenut verrattuna 25,3 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 2,37 %. Jakosuhde on noin 98 % tuloksesta.
National Research osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
National Research liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset National Research -osakkeesta
National Research Corp is a leading provider of analytics and insights for the healthcare industry. The company offers a comprehensive suite of performance measurement solutions to help healthcare organizations enhance patient experiences, improve outcomes, and optimize operational efficiency. By collecting and analyzing data from various sources, National Research Corp enables its clients to make informed decisions and drive positive change in the industry. Through its innovative business model, the company empowers healthcare providers to measure and improve their performance, ultimately leading to better patient care and satisfaction.
National Research Corp is primarily active in the healthcare industry. With years of expertise and a comprehensive suite of research solutions, National Research Corp provides valuable insights and improvement strategies to healthcare organizations. Their services aim to enhance patient satisfaction, manage reputation, and drive overall healthcare excellence. With a strong focus on the healthcare sector, National Research Corp has established itself as a trusted partner for healthcare providers, delivering data-driven solutions to improve quality, safety, and patient experience.
The main competitors of National Research Corp in the market include Press Ganey Holdings Inc., NRC Health Inc., and Advisory Board Company.
National Research Corp is a leading provider of analytics and insights to healthcare organizations. With a rich history spanning over three decades, the company has established itself as a trusted partner in delivering transformative solutions. National Research Corp's journey began in 1981, when it was founded by Samuel K. Hazen and Michael D. Hays to address the emerging need for healthcare quality measurement and improvement. Since then, National Research Corp has consistently pioneered innovative technologies and data-driven approaches to help healthcare providers enhance patient experiences, achieve operational excellence, and drive positive outcomes. Today, their comprehensive suite of services continues to empower healthcare institutions worldwide, making National Research Corp a respected global leader in the industry.
National Research Corp (NRC) has achieved significant milestones throughout its history. These include becoming a leading provider of patient satisfaction surveys and market research to healthcare organizations. NRC has built a reputation for delivering actionable insights and innovative solutions. The company has expanded its services globally and established strategic partnerships with major healthcare organizations. NRC's commitment to excellence has earned it numerous industry accolades, such as being named one of the "Best Places to Work in Healthcare" multiple times. With its strong track record and industry recognition, National Research Corp continues to be a trusted partner for healthcare organizations worldwide.
National Research Corp primarily operates in the United States. With its headquarters in Lincoln, Nebraska, the company provides performance measurement and improvement services to healthcare organizations across all 50 states. National Research Corp's dedication to serving the US healthcare industry has positioned it as a leading provider of patient satisfaction surveys, market insights, and quality improvement solutions.
National Research Corp (NRC) represents a strong set of values and corporate philosophy. With a commitment to excellence, NRC upholds integrity, transparency, and accountability in all its operations. The company places great emphasis on client satisfaction and strives to provide exceptional healthcare performance measurement solutions. NRC values innovation and continuously seeks new ways to improve patient care outcomes. By leveraging advanced data analytics, NRC assists healthcare organizations in delivering high-quality services, promoting positive patient experiences, and achieving operational efficiency. NRC's corporate philosophy revolves around fostering trust and collaboration with clients, driving meaningful advancements in the healthcare industry.
5 analyytikkoa arvioi tällä hetkellä National Research-osaketta: 4 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat National Research-yhtiöltä 118,30 M USD liikevaihtoa ja 0,90 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla National Research-osake noteerataan hintaan 19,58 EUR (21,93 USD).
National Research-osake (NRC) on listattuna 3 pörssissä, muun muassa: NASDAQ (NRC), Frankfurt (NR1A.F), München (NR1A.MU).
National Research Corp (NRC) is a leading company in the field of health care performance tools. Their business model is to provide their customers, mainly in the healthcare industry, with tools and data to improve patient experience, increase compliance with regulations, and enhance profitability. NRC works with various sectors, including hospitals, nursing homes, medical groups, rehabilitation centers, hospices, pharmacies, and health insurers. NRC offers a wide range of products and services to meet their customers' needs. The key products include: - MIND: A digital platform that provides healthcare executives with a 360-degree view of their organization. With MIND, users can access data to make informed decisions, respond to changes, and optimize their business. - Market Insights: A tool that allows customers to gather, analyze, and make informed decisions from data on their patients and competitors. Market Insights helps customers maximize their growth potential and better understand their competitive environment. - Transparency: An online rating system based on patient feedback. Transparency allows customers to collect, measure, and analyze feedback from their patients to improve their patient experience and remain competitive. - Family Experience: A module that enables nursing homes to enhance the experience of patients and family members. Family Experience helps customers increase their home stay rate and improve financial performance. In addition to providing products and services, NRC offers a variety of services to help their customers increase efficiency and profitability. This includes training healthcare staff to optimize the use of NRC's tools. NRC also offers professional services to optimize their customers' business operations, such as consulting services or data analysis. NRC's business model is focused on helping their customers achieve their goals and optimize their business operations. The company earns revenue through the sale of products, services, and additional features. Most of NRC's products are subscription-based and typically billed annually to customers. Overall, NRC's business model is centered around offering data-driven tools and services to their healthcare customers to increase profitability and improve their success in patient experience and their environment. NRC is an established company that has been operating for over 30 years and serves customers in the USA, Canada, and the Middle East.
odotettu liikevaihto National Research on 118,30 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto National Research on 19,71 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
National Research:n hinta-voitto-suhde (P/E) on tällä hetkellä 24,27. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan National Research-osakkeen arvostusta.
National Research:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,04. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii National Research-osakkeen arvostuskennuslukuna.
National Research:n Eulpool-laatuscore on 3/10.
National Research:n ISIN on US6373722023. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
National Research:n WKN on A1WYXP. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
National Research:n ticker on NRC. Tämä pörssinoteeraus käytetään National Research-osakkeiden kauppaan pörssissä.
National Research osake
National Research vertaisryhmä
National Research Ticker
National Research FIGI
Kaikki tunnusluvut ja syvällinen analyysi National Research:sta
Meidän osakeanalyysimme National Research-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut National Research:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: